Genome Analyses of Streptomyces Peucetius ATCC 27952 for the Identification and Comparison of Cytochrome P450 Complement with Other Streptomyces
Overview
Biophysics
Affiliations
We have determined the genome sequence of 8.7 Mb chromosome of Streptomyces peucetius ATCC 27952, which produces clinically important anthracycline chemotherapeutic agents of the polyketide class of antibiotics, daunorubicin and doxorubicin. The cytochrome P450 (CYP) superfamily is represented by 19 sequences in the S. peucetius. Among those, 15 code for functional genes, whereas the remaining four are pseudo genes. CYPs from S. peucetius are phylogenetically close to those of Streptomyces amermitilis. Four CYPs are associated with modular PKS of avermectin and two with doxorubicin biosynthetic gene cluster. CYP252A1 is the new family found in S. peucetius, which shares 38% identity to CYP51 from Streptomyces coelicolor A3 (2). Nine CYPs from S. peucetius are found in the cluster containing various regulatory genes including rar operon, conserved in S. coelicolor A3 (2) and Streptomyces griseus. Although two ferredoxins and four ferredoxin reductases have been identified so far, only one ferredoxin reductase was found in the cluster of CYP147F1 in S. peucetius. To date, 174 CYPs have been described from 45 Streptomyces species in all searchable databases. However, only 18 CYPs are clustered with ferredoxin. The comparative study of cytochrome P450s, ferredoxins, and ferredoxin reductases should be useful for the future development and manipulation of antibiotic biosynthetic pathways.
The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production.
Pudhuvai B, Benes K, curn V, Bohata A, Lencova J, Vrzalova R Microorganisms. 2025; 12(12.
PMID: 39770841 PMC: 11676270. DOI: 10.3390/microorganisms12122639.
DeMars 2nd M, Samora N, Yang S, Garcia-Borras M, Sanders J, Houk K J Biol Chem. 2019; 294(44):15947-15961.
PMID: 31488542 PMC: 6827315. DOI: 10.1074/jbc.RA119.010352.
Cytochrome P450 Enzymes and Their Roles in the Biosynthesis of Macrolide Therapeutic Agents.
Cho M, Han S, Lim Y, Kim V, Kim H, Kim D Biomol Ther (Seoul). 2018; 27(2):127-133.
PMID: 30562877 PMC: 6430224. DOI: 10.4062/biomolther.2018.183.
Rudolf J, Chang C, Ma M, Shen B Nat Prod Rep. 2017; 34(9):1141-1172.
PMID: 28758170 PMC: 5585785. DOI: 10.1039/c7np00034k.
Mo X, Shi C, Gui C, Zhang Y, Ju J, Wang Q Microb Cell Fact. 2017; 16(1):100.
PMID: 28599654 PMC: 5466765. DOI: 10.1186/s12934-017-0718-5.